Diabetes Clinical Trials in Dallas

Showing 381-400 of 593 trials

T and B Cell Responses in Autoimmune Diseases

NCT01947036

The study aims to establish whether defects in immune cell function are shared across multiple autoimmune diseases and whether those problems match to similar genes in the cells.

Type 1 Diabetes MellitusMultiple SclerosisArthritis, Rheumatoid+2 more

National Institute of Allergy and Infectious Diseases (NIAID)68 participantsStarted Jan 2014

New Haven, Connecticut, United States • Atlanta, Georgia, United States • Manhasset, New York, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

NCT00765817

This study will compare the efficacy and safety of exenatide versus placebo in adults whose diabetes is not fully controlled by insulin glargine with or without metformin and/or pioglitazone.

Type 2 Diabetes

AstraZeneca261 participantsStarted Oct 2008

Peoria, Arizona, United States • Phoenix, Arizona, United States • Buena Park, California, United States +56 more locations

T and B Cell Responses in Autoimmune Diseases

Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

Diabetes Trials in Other Cities

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin

Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control

A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.

In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus

Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes

Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

A Study of Aleglitazar in Patients With Type 2 Diabetes

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects

A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin

Other Conditions in Dallas